<p>Peptide concentration in μM. Cell viability was measured 24-hours after the addition of peptide. A, B, C, D: R18 and E, F, G, H: R18D. *<i>p <</i> 0.05 when compared to control [Cont = 100% cell viability (MTS assay) or 0% cell death (LDH assay)]. SDS = wells treated with SDS [SDS = 0% cell viability (MTS assay) or 100% cell death (LDH assay)]. Values are means ± SE; n = 4.</p
[A]. Human red blood cells (1%) were incubated with the listed peptides at the concentrations (μg/ml...
<p>The HUVECs were treated with the indicated concentrations of the TYY peptide. A 0.1% DMSO control...
<p>Morphology of control and treated cells is shown in E. Values are presented as mean ± SEM of thre...
<p>Peptide concentration in μM. Cell viability was measured 24-hours after the addition of peptide. ...
<p>Peptide concentration in μM. Cell viability was measured 24-hours after the addition of peptide. ...
<p>(A) Astrocytes viability induced by WIN. Concentration-dependent viability of WIN (1, 2, 5, 10 μM...
<p><b>A.</b> CHO, <b>B.</b> B16F0 and <b>C.</b> COLO16 cells. Cell cultures (1×10<sup>5</sup>) were ...
<p>Cell toxicity was partially rescued when cells were treated with oligomer reactions of Aβ 1–42 co...
<p>The membrane integrity of the cells after incubation with [D]-K<sub>3</sub>H<sub>3</sub>L<sub>9</...
<p>Toxicity was measured to determine the maximal non-toxic dose test (MNTD) value of the inhibitory...
<p>Cells were plated in wells of a microtiter plate, at 4x10<sup>4</sup> cells/well. After overnight...
<p>RAW 264.7 cells were treated with various concentrations of each peptide or vehicle for 48 h and ...
<p>Survival percentages of SHSY5Y cells incubated with 30 µM Aβs for 72 hours. Wells containing SHSY...
<p>(A) Cell viability of c(RGDyK) peptide or combination pre-treated by 10 nM PTX in U87MG cells. (B...
<p>Confluent astrocytes, plated in 96 well plates, were treated with luminescent organic capped CdSe...
[A]. Human red blood cells (1%) were incubated with the listed peptides at the concentrations (μg/ml...
<p>The HUVECs were treated with the indicated concentrations of the TYY peptide. A 0.1% DMSO control...
<p>Morphology of control and treated cells is shown in E. Values are presented as mean ± SEM of thre...
<p>Peptide concentration in μM. Cell viability was measured 24-hours after the addition of peptide. ...
<p>Peptide concentration in μM. Cell viability was measured 24-hours after the addition of peptide. ...
<p>(A) Astrocytes viability induced by WIN. Concentration-dependent viability of WIN (1, 2, 5, 10 μM...
<p><b>A.</b> CHO, <b>B.</b> B16F0 and <b>C.</b> COLO16 cells. Cell cultures (1×10<sup>5</sup>) were ...
<p>Cell toxicity was partially rescued when cells were treated with oligomer reactions of Aβ 1–42 co...
<p>The membrane integrity of the cells after incubation with [D]-K<sub>3</sub>H<sub>3</sub>L<sub>9</...
<p>Toxicity was measured to determine the maximal non-toxic dose test (MNTD) value of the inhibitory...
<p>Cells were plated in wells of a microtiter plate, at 4x10<sup>4</sup> cells/well. After overnight...
<p>RAW 264.7 cells were treated with various concentrations of each peptide or vehicle for 48 h and ...
<p>Survival percentages of SHSY5Y cells incubated with 30 µM Aβs for 72 hours. Wells containing SHSY...
<p>(A) Cell viability of c(RGDyK) peptide or combination pre-treated by 10 nM PTX in U87MG cells. (B...
<p>Confluent astrocytes, plated in 96 well plates, were treated with luminescent organic capped CdSe...
[A]. Human red blood cells (1%) were incubated with the listed peptides at the concentrations (μg/ml...
<p>The HUVECs were treated with the indicated concentrations of the TYY peptide. A 0.1% DMSO control...
<p>Morphology of control and treated cells is shown in E. Values are presented as mean ± SEM of thre...